PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2011Radiology94 citationsOpen Access

Carotid Artery Atherosclerosis: Effect of Intensive Lipid Therapy on the Vasa Vasorum—Evaluation by Using Dynamic Contrast-enhanced MR Imaging

LDLi DongWKWilliams S. KerwinHCHuijun Chen

Structured PICO

P
Population
28 subjects with established coronary artery disease or carotid artery stenosis ≥15% and apolipoprotein B ≥120 mg/dL, with advanced carotid lesions (>2 mm thick) and interpretable DCE MR imaging. Mean age 55, 82% male, US-based.
I
Intervention
Intensive lipid therapy (atorvastatin 10-80 mg/d alone, or with extended-release niacin 2 g/d, or with niacin plus colesevelam 3.8 g/d) for 1 year.
O
Outcome
Change in transfer constant (K(trans)) of the adventitial vasa vasorum measured by dynamic contrast-enhanced (DCE) MR imaging between baseline and 1-year follow-up.surrogate

Intensive lipid therapy significantly reduces the transfer constant (Ktrans) of the adventitial vasa vasorum in advanced carotid atherosclerosis, suggesting DCE MR imaging can monitor microvascular therapeutic responses.

Limitations

  • Kinetic modeling algorithm requires a minimum of a 2-mm thickness of the carotid arterial wall, precluding evaluation in thinner walls
  • Simplistic assumptions in regard to contrast agent kinetics
  • Underpowered to understand the temporal relationship between lipid depletion and vasa vasorum regression

Abstract

PURPOSE: To investigate whether short-term, intensive lipid therapy leads to changes in microvascular characteristics, as measured by using dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained for this HIPAA-compatible study. Subjects with established coronary artery disease or carotid artery stenosis of 15% or greater determined by using ultrasonography and with levels of apolipoprotein B of 120 mg/dL (1.2 g/L) or greater were enrolled in an ongoing study (clinical trial NCT00715273). All received intensive lipid therapy to achieve targeted high- and low-density lipoprotein cholesterol levels and underwent serial serum monitoring including high-sensitivity C-reactive protein (HsCRP) level measurements. Carotid artery MR imaging examinations including morphologic and DCE MR images were obtained at baseline and 1 year after treatment. In subjects with advanced lesions (>2 mm thick), MR image analysis was performed, including measurement of lipid-rich necrotic core size and kinetic modeling of DCE MR images to assess changes in the transfer constant (K(trans)). The differences in K(trans) between baseline and 1-year follow-up were compared by using the Wilcoxon signed rank test, and associations were assessed by using the Spearman rank correlation coefficient. RESULTS: Twenty-eight subjects with interpretable DCE MR imaging results at both baseline and 1-year follow-up were included. After 1 year of treatment, a significant reduction was found in mean K(trans) (0.085 min(-1) ± 0.037 standard deviation to 0.067 min(-1) ± 0.028, P = .02). Reduction in K(trans) was not significantly correlated with observed reductions in lipid-rich necrotic core size or reductions in HsCRP level. CONCLUSION: These findings suggest that DCE MR imaging may be a useful imaging method for the assessment of the therapeutic response of the vasa vasorum in patients with atherosclerotic plaque.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dong et al. (2011) studied this question.

synapsesocial.com/papers/6a73f6b70375516f85f167f5https://doi.org/10.1148/radiol.11101264
Ask AI
Helpful
Bookmark
Share
View Full Paper